25

Amoxicillin

25 Publications Verification

Cat. No.: HY-B0467A

CAS No.: 26787-78-0

Synonyms: Amoxycillin

Target:

Bacterial Antibiotic

Research Areas:

Infection Cancer

Amoxicillin (Amoxycillin) is an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

25

Amoxicillin trihydrate

25 Publications Verification

Cat. No.: HY-B0467B

CAS No.: 61336-70-7

Synonyms: Amoxycillin trihydrate

Target:

Bacterial Antibiotic

Research Areas:

Infection Metabolic Disease Cancer

Amoxicillin (Amoxycillin) trihydrateis an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin trihydrateis inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

25

Amoxicillin sodium

25 Publications Verification

Cat. No.: HY-B0467

CAS No.: 34642-77-8

Synonyms: Amoxycillin sodium

Target:

Bacterial Antibiotic

Research Areas:

Infection Cancer

Amoxicillin (Amoxycillin) sodium is an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin sodium inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

21

Cholic acid

21 Cited Publications

Cat. No.: HY-N0324

CAS No.: 81-25-4

Category:

Human Gut Microbiota Metabolites Microorganisms Other disease Disease markers Metabolic Disease Endogenous metabolite Disease Research Fields Steroids

Target:

Endogenous Metabolite

Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

21

Cholic acid sodium

21 Cited Publications

Cat. No.: HY-N0324A

CAS No.: 361-09-1

Synonyms: Sodium cholate

Category:

Metabolic Disease Endogenous metabolite Disease Research Fields Steroids

Target:

Endogenous Metabolite

Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

18

D-Mannitol

18 Cited Publications

Cat. No.: HY-N0378

CAS No.: 69-65-8

Synonyms: Mannitol; Mannite

Category:

Natural Products Metabolic Disease Plants Other Families Extract Endogenous metabolite Disease Research Fields Sweeteners Food Research

Target:

Environmental Pollutants Endogenous Metabolite Apoptosis PGC-1α PKA Adrenergic Receptor

D-Mannitol (Mannitol) is an oral, resistant sugar widely used in the food and pharmaceutical industries to promote the absorption and retention of calcium and magnesium through cecal fermentation, while acting as a osmotic diuretic to reduce tissue edema. D-Mannitol can enhance brown fat formation, improve insulin effect, reduce blood sugar levels, And through the start the β₃-adrenergic receptor (β₃-AR), PGC1α and PKA induced by means of white fat cells into brown fat cells . D-Mannitol is commonly used to maintain osmotic pressure between the plant cytoplasm and the culture medium and protect cells when the cell wall is weakened or even removed .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

13

Loperamide

13 Cited Publications

Cat. No.: HY-156131

CAS No.: 53179-11-6

Synonyms: ADL 2-1294

Target:

Opioid Receptor

Research Areas:

Neurological Disease Inflammation/Immunology

Loperamide (ADL 2-1294) is selective and orally active μ opioid receptor agonist with K_i valuess of 3, 48 and 1156 nM against μ, δ and κ opioid receptor, respectively. Loperamide produces antinociception and antihyperalgesia. Loperamide exhibits peripheral selectivity, enhancing fluid, electrolyte, and glucose absorption, reversing PGE₂(HY-101952)- and Cholera toxin (HY-P1446)-induced intestinal secretion, and reducing intestinal motility. Loperamide can be used for the researches of inflammatory pain and protracted diarrhoea .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

11

Omeprazole

11 Cited Publications

Cat. No.: HY-B0113

CAS No.: 73590-58-6

Synonyms: H 16868

Target:

Na+/K+ ATPase Proton Pump Bacterial Cytochrome P450 Apoptosis Autophagy Atg8/LC3 TNF Receptor Interleukin Related

Research Areas:

Infection Neurological Disease Inflammation/Immunology Cancer

Omeprazole (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole also has neuroprotective and antibacterial effects .

Compare

loading...

Please select quantity

August 31

Get Quote

View All Sizes

11

Omeprazole sodium

11 Cited Publications

Cat. No.: HY-B0113A

CAS No.: 95510-70-6

Synonyms: H 16868 sodium

Target:

Na+/K+ ATPase Interleukin Related Proton Pump Cytochrome P450 Bacterial Apoptosis Autophagy TNF Receptor Atg8/LC3

Research Areas:

Infection Inflammation/Immunology

Omeprazole (H 16868) sodium is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole sodium competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole sodium inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole sodium inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole sodium alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole sodium also has neuroprotective and antibacterial effects .

Compare

loading...